FDA's top drug regulator quits as agency officials probe actions

The FDA's top drug regulator, Dr. George Tidmarsh, quit after federal officials began reviewing "serious concerns about his ...

The Workers Left Out of Trump’s Drug-Manufacturing Renaissance

President Trump wants pharmaceutical production to return to the United States. A shuttered factory in Louisiana shows how ...

Novo Nordisk’s weight-loss drug Wegovy could soon have a new sales outlet in the U.S.

Telehealth company Hims & Hers Health Inc. said late Monday it is in “active discussions” with Denmark’s Novo Nordisk A/S to ...
STAT

Experts worry FDA’s credibility is being shredded by scandal and ‘soap opera’

It was the latest shockwave to sweep through an agency beset by all kinds of tumult in recent months. In interviews, ...

Sarepta slumps as gene therapy setback adds to drug pipeline woes

Shares of Sarepta sank 36% before the bell on Tuesday after a trial for two gene-targeted therapies for a muscle-wasting ...

Trump Administration Eases Approval Process for Biosimilar Drugs

The Trump administration is proposing changes to Food and Drug Administration guidelines that would make it less expensive ...
Honolulu Star-Advertiser

FDA’s drug division chief resigns amid ethics concerns, lawsuit

The director of the U.S. Food and Drug Administration’s Center for Drug Evaluation and Research, George Tidmarsh, resigned on Sunday amid serious concerns about his personal conduct, a Department of ...
Disability Scoop

Pediatrics Group Declines To Recommend Drug For Autism Touted By Trump Administration

New professional guidance to the nation's pediatricians advises against using a drug in children with autism that many families are clamoring for after it was hyped by federal officials.